Sign inJoin waitlistJoin the waitlist

Christina Henson

Associate Program Director · University of Oklahoma College of Medicine

Credentials: · · · ·

History

University of Oklahoma College of Medicine
Present
Department of Radiation Oncology · University of Oklahoma College of Medicine
2025–Present
Executive Vice Chair · University of Oklahoma College of Medicine
Present

Radiation Oncology
University of Oklahoma College of Medicine
2013–2017
Preliminary or Transitional Year
2012–2013
University of Oklahoma College of Medicine
2008–2012
University of Oklahoma in Norman
2004–2008

Research

Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations
Review · The Lancet Oncology · 2024 · First of 33 authors · 64 citations
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre,…
The Lancet Oncology · 2024 · 60 citations
Health-Related Quality of Life, Psychosocial Distress and Unmet Needs in Older Patients With Head and Neck Cancer
Review · Frontiers in Oncology · 2022 · Last of 4 authors · 38 citations

Sue Yom
9 papers
CW
Christopher Wilke
5 papers
James Bates
5 papers
William Lydiatt
5 papers
Jonathan Schoenfeld
4 papers
Noah Kalman
4 papers · 1 as a resident
Richard Bakst
4 papers
Anna Lee
3 papers
Greg Krempl
3 papers
Katherine Hutcheson
3 papers
Kathleen Moore
3 papers
Loren Mell
3 papers

Clinical trials

Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer
Principal investigator · Suspended
University of Oklahoma
2026–2027
Virtual Reality Software to Reduce Stress in Cancer Patients
Principal investigator · Withdrawn
University of Oklahoma
2023–2025
Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer
Principal investigator · Completed
Head and Neck Cancer International Group
2022–2023
"QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer
Principal investigator · Active not recruiting · Phase 2
University of Oklahoma
2020–2026